Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Outcomes and molecular profile of oligomonocytic CMML support its consideration as the first stage in the CMML continuum.

Blood advances - 12 Jul 2022

Calvo Xavier, Roman-Bravo David, Garcia-Gisbert Nieves, Rodriguez-Sevilla Juan Jose, Garcia-Avila Sara, Florensa Lourdes, Gibert Joan, Fernández-Rodríguez Concepción, Salido Marta, Puiggros Anna, Espinet Blanca, Colomo Luis, Bellosillo Beatriz, Ferrer Ana, Arenillas Leonor

Abstract excerpt

Patients with oligomonocytic chronic myelomonocytic leukemia (OM-CMML) are currently classified according to the 2017 World Health Organization myelodysplastic syndromes classification. However, recent data support considering OM-CMML as a specific subtype of chronic myelomonocytic leukemia (CMML), given their similar clinical, genomic, and immunophenotypic profiles. The main purpose of our study was to provide...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Leukemia, Myeloid, Acute
Share to Leukemia, Myelomonocytic, Chronic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Myelodysplastic Syndromes

Share to Prognosis

Source

Open in PubMed Open full text

Identifiers

PMID: 35709473
DOI: 10.1182/bloodadvances.2022007359
PMCID: PMC9278296

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Outcomes and molecular profile of oligomonocytic CMML support its consideration as the first stage in the CMML continuum.PMID 35709473Read ↗

[Chronic myelomonocytic leukemia (CMML): recent advances in molecular pathogenesis and treatment].Semantic proximity Read ↗

Chronic Myelomonocytic Leukemia: Insights into Biology, Prognostic Factors, and Treatment.Semantic proximity Read ↗

Chronic myelomonocytic leukemia: myeloproliferative variant.Semantic proximity Read ↗

Oligo-monocytic CMML and other pre-CMML states: Clinical impact, prognostication and management.Semantic proximity Read ↗

Chronic myelomonocytic leukaemia: a concise clinical and pathophysiological reviewSemantic proximity Read ↗

Chronic myelomonocytic leukemia: molecular pathogenesis and therapeutic innovationsSemantic proximity Read ↗

How I investigate chronic myelomonocytic leukemia.Semantic proximity Read ↗

Evolving Understanding of Chronic Myelomonocytic Leukemia: Implications for Future Treatment Paradigms.Semantic proximity Read ↗

Cutting the cord from myelodysplastic syndromes: chronic myelomonocytic leukemia-specific biology and management strategies.Semantic proximity Read ↗

Predicting which subsets of patients with myelodysplastic neoplasms are more likely to progress to overt chronic myelomonocytic leukemia.Semantic proximity Read ↗

Chronic Myelomonocytic Leukemia: History, Pathobiology, Diagnostic Controversies, and Evolving Classification.Semantic proximity Read ↗

Chronic myelomonocytic leukemia: 2013 update on diagnosis, risk stratification, and management.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.